Company Profile
Regeneron Pharmaceuticals Stock Price, News & Analysis
- Ticker:
- REGN
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- United States
Why the stock is moving
REGN is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Regeneron Pharmaceuticals is a biologics-driven biopharmaceutical company built around antibody science, specialty-market execution, and a durable R&D engine. Investors watch both the commercial base and the next wave of pipeline readouts.
Geographic Base and Sector Classification
Headquartered in Tarrytown, New York and listed on NASDAQ, Regeneron is followed within the biologics universe for its exposure to specialty therapeutics, platform depth, and launch execution.
Business Model Characteristics
Regeneron combines commercial products with a platform-led research engine. The market usually focuses on data quality, launch strength, and how efficiently the company turns antibody science into incremental growth.
Position Within the Biotechnology Landscape
Compared with more single-asset biotech names, Regeneron sits closer to the durable-platform end of the landscape, where broad R&D strength and commercial execution support the story.
Future catalysts
Regeneron’s next watchpoints are cemdisiran’s regulatory path, geographic-atrophy and PNH work, and the broader antibody-platform execution. The next checkpoint matters because it tells investors whether the program is still moving on schedule or whether the timeline needs to be reset. A clean outcome also makes it easier to think about the next regulatory or label step instead of just the current filing.
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
Regeneron to Highlight Progress Across Its Metabolic Disease, Ophthalmology and Rare Disease Pipelines at ADA and ENDO
Source: Regeneron Pharmaceuticals
- 02
- 03
Otarmeni™ (lunsotogene parvec) Receives EMA Filing Acceptance for Genetic Hearing Loss
Source: Regeneron Pharmaceuticals
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What does Regeneron Pharmaceuticals do?
Regeneron Pharmaceuticals is a biologics-driven biopharmaceutical company built around antibody science, specialty-market execution, and a durable R&D engine. Investors watch both the commercial base and the next wave of pipeline readouts.
Where is Regeneron Pharmaceuticals based and where is the stock listed?
Regeneron Pharmaceuticals is listed on NASDAQ, Headquartered in Tarrytown, New York and listed on NASDAQ, Regeneron is followed within the biologics universe for its exposure to specialty therapeutics, platform depth, and launch execution., followed in 抗体药物,生物技术.
On which exchange is REGN stock listed?
Regeneron Pharmaceuticals (REGN) is associated with NASDAQ, United States, Biotechnology.
What is Regeneron?
Regeneron’s next watchpoints are cemdisiran’s regulatory path, geographic-atrophy and PNH work, and the broader antibody-platform execution.
Which conditions is Regeneron Pharmaceuticals targeting with Regeneron?
Regeneron’s next watchpoints are cemdisiran’s regulatory path, geographic-atrophy and PNH work, and the broader antibody-platform execution.
How does Regeneron Pharmaceuticals describe recent progress with Regeneron?
Regeneron’s next watchpoints are cemdisiran’s regulatory path, geographic-atrophy and PNH work, and the broader antibody-platform execution.
What is Pharmaceuticals?
Regeneron Pharmaceuticals is a biologics-driven biopharmaceutical company built around antibody science, specialty-market execution, and a durable R&D engine.
What should investors watch for with Pharmaceuticals?
Regeneron’s next watchpoints are cemdisiran’s regulatory path, geographic-atrophy and PNH work, and the broader antibody-platform execution. The next checkpoint matters because it tells investors whether the program is still moving on schedule or whether the timeline needs to be reset. A clean outcome also makes it...
What is Investors?
Investors watch both the commercial base and the next wave of pipeline readouts.